Pan-cancer analysis of whole genomes; Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours; MDM2, MDM4 and EGFR amplifications and hyperprogression in metastatic acral and mucosal melanoma; Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases; Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2D; Distinct mutation patterns reveal melanoma subtypes and influence immunotherapy response in advanced melanoma patients; Enhanced epigenetic profiling of classical human monocytes reveals a specific signature of healthy aging in the DNA methylome; Allele balance bias identifies systematic genotyping errors and false disease associations; Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapy; ClinCNV: Novel method for allele-specific somatic copy-number alterations detection; A statistical approach to detection of copy number variations in PCR-enriched targeted sequencing data; Efficient and flexible Integration of variant characteristics in rare variant association studies using integrated nested Laplace approximation; Transcript-specific loss-of-function variants in VPS16 are enriched in patients with dystonia; Exome-wide analysis of copy number variation shows association of the human leukocyte antigen region with asthma in UK Biobank; Detection of mobile elements insertions for routine clinical diagnostics in targeted sequencing data; ClinCNV: multi-sample germline CNV detection in NGS data; Detection and Characterization of a De Novo Alu Retrotransposition Event Causing NKX2‐1‐Related Disorder; Next-generation phenotyping integrated in a national framework for patients with ultra-rare disorders improves genetic diagnostics and yields new molecular findings; New euchromatic variant dup (11)(p15. 3p15. 1) transmitted through two generations defined by low coverage whole genome sequencing; UV-radiation and MC1R germline mutations are risk factors for the development of conventional and spitzoid melanomas in children and adolescents
